Flamel Technologies SA (FLML)

0.49 4.55
NASDAQ : Health Care
Prev Close 10.76
Open 10.50
Day Low/High 10.13 / 10.81
52 Wk Low/High 7.56 / 15.45
Volume 166.13K
Avg Volume 105.70K
Exchange NASDAQ
Shares Outstanding 41.24M
Market Cap 428.50M
EPS 1.00
P/E Ratio 16.76
Div & Yield N.A. (N.A)

Feuerstein's Biotech-Stock Mailbag

The mailbag returns with questions about Northwest Biotherapeutics, Flamel and, of course, Dendreon.

Glaxo Drug Slump Dousing Flamel

The stock is fighting the underperformance of a second-generation heart drug.

Weekend Blog Watch

Cramer answers questions, buying Google's dip, Ed Zander countdown, and a pure kosher play.

Stockpickr Lists: Keystone Auto Keyed Up

The stock rises on unusual volume as news of an acquisition emerges.

Tuesday's ETF Winners & Losers

Funds tracking homebuilders fall.

Feuerstein's Biotech Mailbag

Vertex Pharma's next big event, Flamel and Dendreon.

Wednesday's ETF Winners & Losers

Wednesday's ETF Winners & Losers

Semiconductor-sector funds are rising.

Health Stocks in Motion

Flamel falls on terminated license pact with Bristol-Myers.

Tops and Bottoms Are Best Seen Afterward

Still, traders try to pick them as they happen. Volume can help.

Market's Brutality May Be Due to Program Trading

We're seeing the worst churn-and-burn environment in more than a year.

Stick With the Strategy

Consistency is key to finding which methods benefit your trading style.

Flamel Shares Bid Up on Bristol-Myers Pact

Flamel Shares Bid Up on Bristol-Myers Pact

The company will get up to $165 million for a diabetes drug it is developing.